Real-World Clinical Practice: Challenges With Glioma Management

Panelists discuss how the updated WHO classification system for gliomas has impacted their treatment approaches, while also addressing the practical difficulties of integrating these changes into routine clinical care.

Now Viewing

EP: 1.Real-World Clinical Practice: Challenges With Glioma Management

EP: 2.Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas

EP: 3.CATNON Trial: Concurrent Versus Adjuvant Temozolomide in Treating WHO Grade 3 Astrocytomas Without 1p/19q Codeletion

EP: 4.IDH Inhibitors in the Treatment of Low-Grade Gliomas

EP: 5.INDIGO Trial: Examining IDH-Mutant Low-Grad Gliomas

EP: 6.Closing Thoughts and Unmet Needs in Glioma Treatment

• How has the new WHO classification system influenced your clinical decision making in glioma management, and what are the main challenges in implementing it in your clinical practice?

Recent Videos